Panel advises against routine prostate test - Boston Globe

Daily Mail

Panel advises against routine prostate test Boston Globe That benefit, he added, must be stacked against a near doubling in the likelihood of being diagnosed with prostate cancer and having side effects from radiation or surgical treatments that will leave 40 out of 1000 men screened with permanent ... FAQ about the new PSA test recommendationsmsnbc.com (blog) Cancer screening disconnect: First breast, now prostateGlobe and Mail The prostate cancer operation that won't leave you incontinentDaily Mail U.S. News & World Report -ABC News -Wall Street Journal all 294 news articles »

600 Patients Recruited in Active Biotech's and Ipsen's tasquinimod Clinical ... - Reuters

600 Patients Recruited in Active Biotech's and Ipsen's tasquinimod Clinical ... Reuters It was concluded that tasquinimod significantly slowed disease progression and improved Progression Free Survival (PFS) in chemonaïve patients with metastatic castrate-resistant prostate cancer (CRPC), alongside an acceptable side effect profile. and more »